On 9/30/20, Windtree Therapeutics Inc (NASDAQ: WINT) stock suffered a major decline of -10.4%, closing at $5.50. This decline was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months and has declined -20.9% during the last week.
Current PriceTarget Research Rating
WINT’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be a major Value Eraser.
WINT has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. WINT has a slightly negative Appreciation Score of 30 and a very low Power Rating of 11, producing the Lowest Value Trend Rating.
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.